These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 34295835)

  • 1. Gut Microbiota in NSAID Enteropathy: New Insights From Inside.
    Wang X; Tang Q; Hou H; Zhang W; Li M; Chen D; Gu Y; Wang B; Hou J; Liu Y; Cao H
    Front Cell Infect Microbiol; 2021; 11():679396. PubMed ID: 34295835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Microbiota on NSAID Enteropathy: A Systematic Review of Current Knowledge and the Role of Probiotics.
    Rekatsina M; Paladini A; Cifone MG; Lombardi F; Pergolizzi JV; Varrassi G
    Adv Ther; 2020 May; 37(5):1933-1945. PubMed ID: 32291647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological stress exacerbates NSAID-induced small bowel injury by inducing changes in intestinal microbiota and permeability via glucocorticoid receptor signaling.
    Yoshikawa K; Kurihara C; Furuhashi H; Takajo T; Maruta K; Yasutake Y; Sato H; Narimatsu K; Okada Y; Higashiyama M; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Tajiri H; Hokari R
    J Gastroenterol; 2017 Jan; 52(1):61-71. PubMed ID: 27075753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiota Plays a Key Role in Non-Steroidal Anti-Inflammatory Drug-Induced Small Intestinal Damage.
    Otani K; Tanigawa T; Watanabe T; Shimada S; Nadatani Y; Nagami Y; Tanaka F; Kamata N; Yamagami H; Shiba M; Tominaga K; Fujiwara Y; Arakawa T
    Digestion; 2017; 95(1):22-28. PubMed ID: 28052268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NSAID enteropathy and bacteria: a complicated relationship.
    Syer SD; Blackler RW; Martin R; de Palma G; Rossi L; Verdu E; Bercik P; Surette MG; Aucouturier A; Langella P; Wallace JL
    J Gastroenterol; 2015 Apr; 50(4):387-93. PubMed ID: 25572030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The microbiota-derived metabolite indole decreases mucosal inflammation and injury in a murine model of NSAID enteropathy.
    Whitfield-Cargile CM; Cohen ND; Chapkin RS; Weeks BR; Davidson LA; Goldsby JS; Hunt CL; Steinmeyer SH; Menon R; Suchodolski JS; Jayaraman A; Alaniz RC
    Gut Microbes; 2016 May; 7(3):246-61. PubMed ID: 27007819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NSAID enteropathy: could probiotics prevent it?
    Montalto M; Gallo A; Gasbarrini A; Landolfi R
    J Gastroenterol; 2013 Jun; 48(6):689-97. PubMed ID: 22875474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of Saccharomyces boulardii CNCM I-745 in an experimental model of NSAID-induced enteropathy.
    Simon O'Brien E; Robert A; Gauthier D; Le Cavorzin A; Planchais J; Roux X; Verleye M; Castagné V
    Benef Microbes; 2023 Sep; 14(3):239-253. PubMed ID: 37646075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NSAIDs and the small bowel.
    Tai FWD; McAlindon ME
    Curr Opin Gastroenterol; 2018 May; 34(3):175-182. PubMed ID: 29438118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota.
    Blackler RW; Motta JP; Manko A; Workentine M; Bercik P; Surette MG; Wallace JL
    Br J Pharmacol; 2015 Feb; 172(4):992-1004. PubMed ID: 25297699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSAID-induced small intestinal damage--roles of various pathogenic factors.
    Takeuchi K; Satoh H
    Digestion; 2015; 91(3):218-32. PubMed ID: 25791157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSAID-induced enteropathy: the current state of the problem.
    Svistunov AA; Osadchuk MA; Kireeva NV; Hudarova AA; Achkasov EE
    Ter Arkh; 2018 Aug; 90(8):95-100. PubMed ID: 30701943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota Mediates Protection Against Enteropathy Induced by Indomethacin.
    Xiao X; Nakatsu G; Jin Y; Wong S; Yu J; Lau JY
    Sci Rep; 2017 Jan; 7():40317. PubMed ID: 28067296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [NSAID-induced gastroenteropathy].
    Kim JW
    Korean J Gastroenterol; 2008 Sep; 52(3):134-41. PubMed ID: 19077509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [NSAID enteropathy].
    Kareva EN
    Ter Arkh; 2020 Apr; 92(2):85-92. PubMed ID: 32598724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?
    Adebayo D; Bjarnason I
    Postgrad Med J; 2006 Mar; 82(965):186-91. PubMed ID: 16517800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease.
    Utzeri E; Usai P
    World J Gastroenterol; 2017 Jun; 23(22):3954-3963. PubMed ID: 28652650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drugs, proton pump inhibitors, and gastrointestinal injury: contrasting interactions in the stomach and small intestine.
    Marlicz W; Loniewski I; Grimes DS; Quigley EM
    Mayo Clin Proc; 2014 Dec; 89(12):1699-709. PubMed ID: 25440891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Present status and strategy of NSAIDs-induced small bowel injury.
    Higuchi K; Umegaki E; Watanabe T; Yoda Y; Morita E; Murano M; Tokioka S; Arakawa T
    J Gastroenterol; 2009; 44(9):879-88. PubMed ID: 19568687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ameliorating Role of Hydrogen-Rich Water Against NSAID-Induced Enteropathy via Reduction of ROS and Production of Short-Chain Fatty Acids.
    Akita Y; Higashiyama M; Kurihara C; Ito S; Nishii S; Mizoguchi A; Inaba K; Tanemoto R; Sugihara N; Hanawa Y; Wada A; Horiuchi K; Okada Y; Narimatsu K; Komoto S; Tomita K; Takei F; Satoh Y; Saruta M; Hokari R
    Dig Dis Sci; 2023 May; 68(5):1824-1834. PubMed ID: 36478314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.